Effects of The Telerehabilitation-Based Exercise Program in Liver Transplant Patients
1 other identifier
interventional
140
1 country
1
Brief Summary
This randomized controlled study aims to evaluate the effects of a telerehabilitation-based exercise program on muscle strength, exercise capacity, fatigue level, and cognitive status in adult liver transplant recipients. Liver transplantation is a major surgical procedure, and patients may experience reduced physical capacity, muscle weakness, and fatigue during recovery. Exercise-based rehabilitation may help improve these outcomes, but access to in-person rehabilitation programs may be limited after discharge. Participants will be randomly assigned to either a control group receiving routine post-transplant care or an intervention group participating in a supervised telerehabilitation exercise program. The intervention consists of a 12-week program conducted twice weekly via video communication with a physiotherapist. Outcomes will be assessed at baseline and after completion of the program. The study seeks to determine whether a structured, remotely supervised exercise program can improve functional recovery and reduce fatigue in liver transplant patients, potentially offering an accessible rehabilitation option after hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2025
CompletedFirst Submitted
Initial submission to the registry
February 13, 2026
CompletedFirst Posted
Study publicly available on registry
February 20, 2026
CompletedFebruary 25, 2026
February 1, 2026
11 months
February 13, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
6-Minute Walk Test (6MWT) Distance
Change in functional exercise capacity measured by the distance (meters) walked during the 6-minute walk test.
Baseline (pre-intervention) and end of the 12-week intervention period
Fatigue Severity Scale
Change in fatigue severity measured using the Fatigue Severity Scale (FSS). Total scores range from 9 to 63, with higher scores indicating greater fatigue severity.
Baseline (pre-intervention) and end of the 12-week intervention period
Secondary Outcomes (3)
Peripheral Oxygen Saturation (SpO₂)
Baseline and end of 12 weeks
Montreal Cognitive Assessment (MoCA) Score
Baseline and end of 12 weeks
Heart Rate
Baseline and end of 12 weeks
Study Arms (2)
Telerehabilitation Exercise Group
EXPERIMENTALParticipants assigned to this arm received a structured telerehabilitation-based exercise program in addition to routine post-transplant care. The program was conducted for 12 weeks, twice weekly, via real-time video communication with a physiotherapist. Sessions included warm-up exercises, posture and breathing exercises, isometric strengthening exercises, functional movements such as sit-to-stand, walking training, and cool-down stretching. Exercise intensity was maintained at a moderate level and progressed gradually throughout the program.
Control Group
NO INTERVENTIONParticipants assigned to this arm continued their routine daily activities and received standard post-transplant care without participating in a structured or supervised exercise or rehabilitation program during the study period.
Interventions
Participants in this group received a structured telerehabilitation-based exercise program delivered under real-time supervision by a physiotherapist. The intervention lasted 12 weeks and was conducted twice weekly via video communication. Each session lasted approximately 30-45 minutes and included warm-up exercises, posture and breathing exercises, isometric strengthening exercises for upper and lower extremities, functional exercises such as sit-to-stand, and walking training, followed by cool-down and stretching. Exercise intensity was maintained at a moderate level based on perceived exertion, and progression was applied throughout the program by increasing repetitions and duration to ensure adaptation and safety. Participants were initially instructed face-to-face before discharge and then continued the program remotely after discharge.
Eligibility Criteria
You may qualify if:
- Adult liver transplant recipients aged 18 years or older
- Medically stable and cleared for participation in an exercise program
- Able to communicate and cooperate with the researcher
- Literate and able to understand instructions
- No orthopedic or neurological condition that would limit exercise participation
- Approximately one month post-discharge following liver transplantation
- Willing to participate and provide informed consent
You may not qualify if:
- Presence of medical conditions that contraindicate exercise participation
- Severe cardiovascular, respiratory, neurological, or musculoskeletal disorders that could interfere with the exercise program
- Cognitive impairment preventing understanding of instructions or participation in assessments
- Postoperative complications requiring activity restriction
- Participation in another structured exercise or rehabilitation program during the study period
- Refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inonu University Turgut Ozal Medical Center
Malatya, 4400, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ilker Demir, PhD
Inonu University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2026
First Posted
February 20, 2026
Study Start
October 12, 2024
Primary Completion
September 15, 2025
Study Completion
November 28, 2025
Last Updated
February 25, 2026
Record last verified: 2026-02